EMC Instytut Medyczny SA

Warsaw Stock Exchange EMC.WA

EMC Instytut Medyczny SA EBITDA for the year ending December 31, 2023: USD 14.87 M

EMC Instytut Medyczny SA EBITDA is USD 14.87 M for the year ending December 31, 2023, a 153.13% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

EMC Instytut Medyczny SA EBITDA for the year ending December 31, 2022 was USD 5.87 M, a -31.84% change year over year.
EMC Instytut Medyczny SA EBITDA for the year ending December 31, 2021 was USD 8.62 M, a 50.02% change year over year.
EMC Instytut Medyczny SA EBITDA for the year ending December 31, 2020 was USD 5.74 M, a 2.23% change year over year.
EMC Instytut Medyczny SA EBITDA for the year ending December 31, 2019 was USD 5.62 M, a 257.69% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Warsaw Stock Exchange: EMC.WA

EMC Instytut Medyczny SA

CEO	Mr. Karol Piasecki
IPO Date	Aug. 17, 2005
Location	Poland
Headquarters	ul. Pilczycka 144-148
Employees	2,026
Sector	Healthcare
Industries Hospitals & Clinics Biotechnology Dental Care Drugstores & Retail Pharmacies Investment Banking & Asset Management Personal Care Private Equity Telehealth

Description

EMC Instytut Medyczny SA owns hospitals and outpatient clinics in the private medical services market in Poland. The company was founded in 2001 and is based in Wroclaw, Poland.

Key trends

Past 5 years